GH1 and hepatocellular carcinoma: Importantly, HCC patients with high GH had a shorter OS (median = 7.59 months, 95% confidence interval (CI): 6.34, 9.36) vs. patients with normal levels of GH (22.74 months, 95% CI: 19.52, 27.47) (P<0.0001) (Figure 2A; Table 3).